- 3.20.2024
- Podcast
Psychedelic Conversations: Amber Capone - VETS: Veterans Exploring Treatment Solutions #111
In this episode we discuss Amber's personal journey of supporting her husband through multiple combat deployments and their struggles transitioning back to civilian life, leading to the discovery of psychedelic therapy as a path to healing. Her story is one of love, resilience, and the pursuit of healing, not only for her husband but for countless other veterans facing similar challenges. We delve into the challenges spouses face, the importance of community support, and the potential of psychedelics like ibogaine and 5-MeO-DMT in treating PTSD, TBI, and fostering a deeper connection to life and purpose. As we explore the growth of VETS and their mission to expand access to psychedelic therapies, Amber's insights highlight the importance of individualized approaches, legislative change, and ongoing personal work in the healing journey.
- 3.14.2024
- News
THE WASHINGTON POST: Psychedelic drug ibogaine hailed as healing. U.S. patients ask why it’s illegal
Stephen Jones spent three decades in Navy Special Operations, his brain bearing the imprint of traumatic injury. Yoga and a psychedelic called ibogaine eased his suffering. (Michael A. McCoy for The Washington Post)
- 2.21.2024
- News
The Virginian Pilot: VA to explore psychedelic treatments for veterans with PTSD: It could be ‘life-changing,’ retired Navy SEALs say
For the first time since the 1960s, the Department of Veterans Affairs will begin funding studies that may open the door for using plant-based psychedelics to treat military veterans diagnosed with mental illnesses.
- 2.21.2024
The Orange County Register: It’s not too late for California to be a pioneer in psychedelic-assisted therapies in 2024
As legislative momentum builds around psychedelic-assisted therapies, California emerges as a frontrunner, and Governor Gavin Newsom’s support is a promising sign.
- 2.20.2024
- News
The Washington Post: VA considers using psychedelic drugs to fight PTSD among veterans
Psychedelics are becoming so mainstream that the Department of Veterans Affairs is examining the use of MDMA — also known as ecstasy — and psilocybin, the active ingredient in psychedelic mushrooms, to fight post-traumatic stress disorder (PTSD) and depression.